Detection of apoptotic cells in cerebrospinal fluid of patients suffering from neurological disease

Journal of Neuroimmunology

Volumn 188, Issue 1-2, 2007, Pages 175-180

  Goertsches, R ^a   Knappe, S ^a   Mix, E ^a   Zettl, U K ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Apoptosis; Bcl 2; Cerebrospinal fluid; Fas; Immunohistochemistry; In situ tailing

Indexed keywords

DNA FRAGMENT; FAS ANTIGEN; PROTEIN BCL 2;

ANALYTIC METHOD; APOPTOSIS; ARTICLE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DISEASE; LYMPHOCYTE; MOLECULAR BIOLOGY; MORPHOLOGY; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; PRIORITY JOURNAL;

ANTIGENS, CD95; APOPTOSIS; CEREBROSPINAL FLUID; DNA FRAGMENTATION; FEMALE; HUMANS; LYMPHOCYTES; MALE; NERVOUS SYSTEM DISEASES; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 34447641638     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2007.06.004     Document Type: Article

References (41)

1. Achiron A., Gurevich M., Friedman N., Kaminski N., and Mandel M. Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity. Ann. Neurol. 55 (2004) 410-417
2. Bellgrau D., and Duke R.C. Apoptosis and CD95 ligand in immune privileged sites. Int. Rev. Immunol. 18 (1999) 547-562
3. Bilinska M., Frydecka I., Podemski R., and Gruszka E. Fas expression on T cells and sFas in relapsing-remitting multiple sclerosis. Acta Neurol. Scand. 107 (2003) 387-393
4. Ciusani E., Frigerio S., Gelati M., Corsini E., Dufour A., Nespolo A., La Mantia L., Milanese C., Massa G., and Salmaggi A. Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients. J. Neuroimmunol. 82 (1998) 5-12
5. Cohen J.J., Duke R.C., Fadok V.A., and Sellins K.S. Apoptosis and programmed cell death in immunity. Annu. Rev. Immunol. 10 (1992) 267-293
6. Comi C., Leone M., Bonissoni S., DeFranco S., Bottarel F., Mezzatesta C., Chiocchetti A., Perla F., Monaco F., and Dianzani U. Defective T cell Fas function in patients with multiple sclerosis. Neurology 55 (2000) 921-927
7. Correale J., Gilmore W., Li S., Walsh J., Bassani M.M., Lund B., Arias M., and Weiner L.P. Resistance to glucocorticoid-induced apoptosis in PLP peptide-specific T cell clones from patients with progressive MS. J. Neuroimmunol. 109 (2000) 197-210
8. Engelhardt B., and Ransohoff R.M. The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms. Trends Immunol. 26 (2005) 485-495
9. Gold R., Schmied M., Giegerich G., Breitschopf H., Hartung H.P., Toyka K.V., and Lassmann H. Differentiation between cellular apoptosis and necrosis by the combined use of in situ tailing and nick translation techniques. Lab. Invest. 71 (1994) 219-225
10. Gold R., Hartung H.P., and Lassmann H. T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci. 20 (1997) 399-404
11. Hickey W.F. Basic principles of immunological surveillance of the normal central nervous system. Glia 36 (2001) 118-124
12. Huang W.X., Huang P., Gomes A., and Hillert J. Apoptosis mediators FasL and TRAIL are upregulated in peripheral blood mononuclear cells in MS. Neurology 55 (2000) 928-934
13. Ichikawa H., Ota K., and Iwata M. Increased Fas antigen on T cells in multiple sclerosis. J. Neuroimmunol. 71 (1996) 125-129
14. Inoue A., Koh C.S., Sakai T., Yamazaki M., Yanagisawa N., Usuku K., and Osame M. Detection of the soluble form of the Fas molecule in patients with multiple sclerosis and human T-lymphotropic virus type I-associated myelopathy. J. Neuroimmunol. 75 (1997) 141-146
15. + T cells in multiple sclerosis. J. Neuroimmunol. 180 (2006) 147-158
16. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26 (1972) 239-257
17. + T cells: evidence for trafficking through choroid plexus and meninges via P-selectin. Proc. Natl. Acad. Sci. U. S. A. 100 (2003) 8389-8394
18. Kohji T., and Matsumoto Y. Coexpression of Fas/FasL and Bax on brain and infiltrating T cells in the central nervous system is closely associated with apoptotic cell death during autoimmune encephalomyelitis. J. Neuroimmunol. 106 (2000) 165-171
19. Krammer P.H. CD95's deadly mission in the immune system. Nature 407 (2000) 789-795
20. Kuhlmann T., Lucchinetti C., Zettl U.K., Bitsch A., Lassmann H., and Bruck W. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions. Glia 28 (1999) 34-39
21. Lopatinskaya L., Zwemmer J., Uitdehaag B., Lucas K., Polman C., and Nagelkerken L. Mediators of apoptosis Fas and FasL predict disability progression in multiple sclerosis over a period of 10 years. Mult. Scler. 12 (2006) 704-709
22. Macchi B., Matteucci C., Nocentini U., Caltagirone C., and Mastino A. Impaired apoptosis in mitogen-stimulated lymphocytes of patients with multiple sclerosis. NeuroReport 10 (1999) 399-402
23. Mahovic D., Petravic D., Petelin Z., Zurak N., Horvat G., and Hajnsek S. Level of sFas/APO 1 in serum and cerebrospinal fluid in multiple sclerosis. Clin. Neurol. Neurosurg. 106 (2004) 230-232
24. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.-P., Lublin F.D., McFarland H.F., Paty D.W., Polman C.H., Reingold S.C., Sandberg-Wollheim M., Sibley W., Thompson A., van den Noort S., Weinshenker B.Y., and Wolinsky J.S. Recommended diagnostic criteria for multiple sclerosis: guidelines from the international panel on the diagnosis of multiple sclerosis. Ann. Neurol. 50 (2001) 121-127
25. Merrill J.E., and Scolding N.J. Mechanisms of damage to myelin and oligodendrocytes and their relevance to disease. Neuropathol. Appl. Neurobiol. 25 (1999) 435-458
26. Okuda Y., Apatoff B.R., and Posnett D.N. Apoptosis of T cells in peripheral blood and cerebrospinal fluid is associated with disease activity of multiple sclerosis. J. Neuroimmunol. 171 (2006) 163-170
27. Perry V.H., Bell M.D., Brown H.C., and Matyszak M.K. Inflammation in the nervous system. Curr. Opin. Neurobiol. 5 (1995) 636-641
28. Ransohoff R.M., Kivisakk P., and Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3 (2003) 569-581
29. Rathmell J.C., and Thompson C.B. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109 (2002) S97-S107
30. + cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 10399-10404
31. Semra Y.K., Seidi O.A., and Sharief M.K. Disease activity in multiple sclerosis correlates with T lymphocyte expression of the inhibitor of apoptosis proteins. J. Neuroimmunol. 122 (2002) 159-166
32. Sharief M.K. Impaired Fas-independent apoptosis of T lymphocytes in patients with multiple sclerosis. J. Neuroimmunol. 109 (2000) 236-243
33. Sharief M.K. Increased cellular expression of the caspase inhibitor FLIP in intrathecal lymphocytes from patients with multiple sclerosis. J. Neuroimmunol. 111 (2000) 203-209
34. Sharief M.K., Douglas M., Noori M., and Semra Y.K. The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis. J. Neuroimmunol. 125 (2002) 155-162
35. Strasser A., Harris A.W., Huang D.C., Krammer P.H., and Cory S. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J. 14 (1995) 6136-6147
36. Vaux D.L., and Flavell R.A. Apoptosis genes and autoimmunity. Curr. Opin. Immunol. 12 (2000) 719-724
37. Wekerle H., Linington C., Lassmann H., and Meyermann R. Cellular immune reactivity within the CNS. Trends Neurosci. 9 (1986) 271-277
38. Zang Y.C., Kozovska M.M., Hong J., Li S., Mann S., Killian J.M., Rivera V.M., and Zhang J.Z. Impaired apoptotic deletion of myelin basic protein-reactive T cells in patients with multiple sclerosis. Eur. J. Immunol. 29 (1999) 1692-1700
39. Zettl U.K., Mix E., Gold R., Rothe G., and Hartung H.P. Detection of oxidative burst and apoptotic cell death in cerebrospinal fluid (CSF) and blood. J. Lab. Med. 20 (1996) 176-177
40. Zettl U.K., Kuhlmann T., and Bruck W. Bcl-2 expressing T lymphocytes in multiple sclerosis lesions. Neuropathol. Appl. Neurobiol. 24 (1998) 202-208
41. Zipp F., Otzelberger K., Dichgans J., Martin R., and Weller M. Serum CD95 of relapsing remitting multiple sclerosis patients protects from CD95-mediated apoptosis. J. Neuroimmunol. 86 (1998) 151-154